Monthly information related to total number of voting rights and shares composing the share capital - October 31, 2018
LYON, France, Nov. 05, 2018 (GLOBE NEWSWIRE) --
Article 223-16 of general regulation of French Autorité des Marchés Financiers
Lyon - France
Listing markets:
Euronext Paris from Euronext (Market segment B - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (ERYP.PA)
Website : www.erytech.com
Date | Total of shares composing the share capital | Total of brut(1) voting rights | Total of net(2) voting rights |
December 31, 2017 | 17 937 559(3) | 19 545 443 | 19 542 943 |
January 1, 2018 | 17 940 035(3) | 19 543 919(3) | 19 541 419 |
February 28, 2018 | 17 940 035 | 19 546 219 | 19 543 719 |
March 31, 2018 | 17 940 035 | 19 546 221 | 19 543 721 |
April 30, 2018 | 17 940 035 | 19 554 221 | 19 551 721 |
May 31, 2018 | 17 940 035 | 19 543 991 | 19 541 491 |
June 30, 2018 | 17 940 035 | 19 525 991 | 19 523 491 |
July 31, 2018 | 17 940 035 | 19 525 991 | 19 523 491 |
August 31, 2018 | 17 940 035 | 19 525 991 | 19 523 491 |
September 30, 2018 | 17 940 035 | 19 525 741 | 19 523 241 |
October 31, 2018 | 17 940 035 | 19 525 741 | 19 523 241 |
(1) | Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights. |
(2) | Without treasury shares |
(3) | The number of shares and voting rights increased due to issuance of shares consequently to warrants exercises and or end of vesting periods of free shares which a Board of Director will take notice of in the future. |
This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Erytech Pharma S.A. via GlobeNewswire
HUG#2224112
